2004
DOI: 10.1016/j.peptides.2003.10.019
|View full text |Cite
|
Sign up to set email alerts
|

Trefoil factor family (TFF) peptides and cancer progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
78
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 114 publications
(81 citation statements)
references
References 165 publications
3
78
0
Order By: Relevance
“…Recent studies indicate that TFFs exert dual roles during normal development and malignancies associated with the digestive tract, especially inflammatory processes and cancer progression (Emami et al, 2004;Dhar et al, 2005). During transient injury of the mucosa, TFFs display protective roles on mucosal repair and inflammation.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Recent studies indicate that TFFs exert dual roles during normal development and malignancies associated with the digestive tract, especially inflammatory processes and cancer progression (Emami et al, 2004;Dhar et al, 2005). During transient injury of the mucosa, TFFs display protective roles on mucosal repair and inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Trefoil factors TFF1 (formerly designated pS2), TFF2 (Spasmolytic Polypeptide), and TFF3 (intestinal trefoil factor) are 7-12 kDa protease-resistant proteins mainly secreted by mucus-secreting cells in the gastrointestinal tract (reviewed in Emami et al, 2004). TFFs are efficient motogenic agents with beneficial effects on the gastrointestinal epithelia, promoting wound healing and mucosal restitution after local injury.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the current literature, TFF peptides are discussed as tumor suppressors and potential tumor progression or oncogenic factors [14]. On the one hand, TFF peptides are overexpressed in several human solid tumors [15,16,17]. TFF3 overexpression is frequently observed in human cancers e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the absence of an identified cell surface receptor for TFF2, there is nevertheless clear evidence that TFF2 and TFF3 rapidly activate signal transduction pathways (17,18). TFF3 prevents cell death via activation of the serine/threonine kinase AKT in colon cancer cell lines (19).…”
mentioning
confidence: 99%